Eden Research

Eden Research PLC Eden Research plc is an AIM-listed public company with intellectual property and expertise in microencapsulation, terpenes and environmentally friendly technologies. We are developing these technologies through innovative research and a series of appropriate commercial production, marketing and distribution partnerships. Based in Cirencester in the UK, we are developing natural solutions to agricultural, animal, human health and industrial problems, with our primary focus being the use of terpenes to create an exciting array of low-risk but effective agricultural chemicals. Eden's products take advantage of the biocidal efficacy of naturally occurring chemicals produced by plant defence mechanisms and, in particular, the antimicrobial properties of terpenes. Terpenes are naturally occurring, low-toxicity botanical substances produced by most plants as part of their defence mechanisms. The initial Eden approach has involved the use of GRAS substances, that is, compounds 'Generally Recogised As Safe' for human consumption or application to food crops. Board of Directors: - Tom Lupton, Non-executive Chairman - Sean Smith, Chief Executive Officer - Alexander John Abrey, Chief Financial Officer - Robin Cridland, Non-executive Director Company No. 03071324
Type
Public
HQ
Cirencester, GB
Founded
1996
Size (employees)
5 (est)-16%
Eden Research was founded in 1996 and is headquartered in Cirencester, GB

Eden Research Office Locations

Eden Research has offices in Cirencester and London
Cirencester, GB (HQ)
3 15 Gosditch St
London, GB
Walbrook Pr Ltd 4 Lombard Street

Eden Research Data and Metrics

Eden Research Financial Metrics

Eden Research's revenue was reported to be £883.3 k in FY, 2015 which is a 785% increase from the previous period.
Numbers are in £, GBP

Revenue (FY, 2015)

883.3 k

Revenue growth (FY, 2014 - FY, 2015), %

785%

Gross profit (FY, 2015)

784.6 k

Gross profit margin (FY, 2015), %

89%

Net income (FY, 2015)

(1.1 m)

Market capitalization (26-May-2017)

17.6 m

Closing share price (26-May-2017)

0.1

Cash (31-Dec-2015)

148.4 k
Eden Research's current market capitalization is £17.6 m.
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015

Revenue

80.2 k99.9 k883.3 k

Revenue growth, %

24%785%

Cost of goods sold

98.7 k

Gross profit

784.6 k

Gross profit Margin, %

89%

Operating expense total

1.9 m

Pre tax profit

(1.6 m)(3 m)(1.2 m)

Net Income

(1.6 m)(3 m)(1.1 m)
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015

Cash

311.3 k415 k148.4 k

Accounts Receivable

117.5 k34.4 k145 k

Current Assets

441.1 k477.5 k312.8 k

PP&E

923.1 k

Goodwill

6.1 m5.9 m5.5 m

Total Assets

6.5 m6.4 m6.8 m

Accounts Payable

291.2 k291.7 k326.9 k

Current Liabilities

854.1 k458.3 k752.6 k

Retained Earnings

(1.6 m)(3 m)(1.1 m)

Total Equity

5.7 m5.9 m6 m

Financial Leverage

1.2 x1.1 x1.1 x
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

(1.2 m)(930.3 k)(104.9 k)

Cash From Financing Activities

1.4 m1.5 m(30 k)

Income Taxes Paid

40.3 k28.3 k101.3 k
Numbers are in £, GBPY, 2015

Revenue/Employee

147.2 k

Financial Leverage

1.1 x

Eden Research Market Value History

Eden Research Revenue Breakdown

Eden Research Online and Social Media Presence

Eden Research News and Updates

Eden Research Company Life and Culture

You may also be interested in